RemeGen Co., Ltd.
General ticker "REGMF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.8B (TTM average)
RemeGen Co., Ltd. follows the US Stock Market performance with the rate: 36.9%.
Estimated limits based on current volatility of -0.0%: low 12.10$, high 12.09$
Short-term REGMF quotes
Long-term REGMF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY767.77MM | CNY1,076.13MM | CNY1,710.15MM |
| Operating Expenses | CNY1,821.85MM | CNY2,578.48MM | CNY3,080.98MM |
| Operating Income | CNY-1,054.08MM | CNY-1,502.35MM | CNY-1,370.83MM |
| Non-Operating Income | CNY55.25MM | CNY-8.88MM | CNY-97.53MM |
| Interest Expense | CNY6.76MM | CNY23.09MM | CNY72.38MM |
| R&D Expense | CNY982.08MM | CNY1,306.31MM | CNY1,539.78MM |
| Income(Loss) | CNY-998.83MM | CNY-1,511.23MM | CNY-1,468.36MM |
| Net Income(Loss)* | CNY-998.83MM | CNY-1,511.23MM | CNY-1,468.36MM |
| Stockholders Equity | CNY4,980.30MM | CNY3,437.27MM | CNY1,986.20MM |
| Inventory | CNY522.67MM | CNY741.56MM | CNY659.37MM |
| Assets | CNY6,021.19MM | CNY5,528.24MM | CNY5,498.52MM |
| Operating Cash Flow | CNY-1,263.69MM | CNY-1,501.83MM | CNY-1,176.60MM |
| Capital expenditure | CNY757.52MM | CNY852.74MM | CNY265.28MM |
| Investing Cash Flow | CNY-841.56MM | CNY-817.65MM | CNY-185.91MM |
| Financing Cash Flow | CNY2,426.95MM | CNY978.31MM | CNY1,392.97MM |
| Earnings Per Share** | CNY-1.88 | CNY-2.80 | CNY-2.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.